ATE180973T1 - Paroxetin enthaltende tabletten und verfahren - Google Patents

Paroxetin enthaltende tabletten und verfahren

Info

Publication number
ATE180973T1
ATE180973T1 AT95904476T AT95904476T ATE180973T1 AT E180973 T1 ATE180973 T1 AT E180973T1 AT 95904476 T AT95904476 T AT 95904476T AT 95904476 T AT95904476 T AT 95904476T AT E180973 T1 ATE180973 T1 AT E180973T1
Authority
AT
Austria
Prior art keywords
tablets
method containing
containing paroxetine
paroxetine
Prior art date
Application number
AT95904476T
Other languages
English (en)
Inventor
Ram Dutta Pathak
David George Dr Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE180973(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE180973T1 publication Critical patent/ATE180973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95904476T 1993-12-15 1994-12-14 Paroxetin enthaltende tabletten und verfahren ATE180973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation

Publications (1)

Publication Number Publication Date
ATE180973T1 true ATE180973T1 (de) 1999-06-15

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904476T ATE180973T1 (de) 1993-12-15 1994-12-14 Paroxetin enthaltende tabletten und verfahren

Country Status (35)

Country Link
US (1) US6113944A (de)
EP (1) EP0734260B2 (de)
JP (1) JP3037757B2 (de)
KR (1) KR100367796B1 (de)
CN (1) CN1071116C (de)
AP (1) AP540A (de)
AT (1) ATE180973T1 (de)
AU (1) AU697982B2 (de)
BG (1) BG62755B1 (de)
BR (1) BR9408219A (de)
CA (4) CA2274387A1 (de)
CZ (1) CZ287891B6 (de)
DE (1) DE69419033T2 (de)
DK (1) DK0734260T4 (de)
DZ (1) DZ1835A1 (de)
ES (1) ES2132610T5 (de)
FI (1) FI962445A0 (de)
GB (1) GB9325644D0 (de)
GR (1) GR3031047T3 (de)
HU (1) HUT75880A (de)
IL (1) IL111978A (de)
MA (1) MA23395A1 (de)
MY (1) MY112123A (de)
NO (1) NO307366B1 (de)
NZ (1) NZ277790A (de)
OA (1) OA10297A (de)
PL (1) PL314980A1 (de)
RO (1) RO115413B1 (de)
RU (1) RU2146141C1 (de)
SA (1) SA94150373B1 (de)
SI (1) SI0734260T2 (de)
SK (1) SK282620B6 (de)
UA (1) UA42745C2 (de)
WO (1) WO1995016448A1 (de)
ZA (1) ZA949900B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EE03970B1 (et) 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
EP1313474A2 (de) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetin-zusammensetzungen und verfahren zu deren herstellung
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
HRP20031073A2 (en) 2001-07-31 2004-04-30 Lundbeck & Co As H Crystalline composition containing escitalopram
WO2003044012A1 (en) * 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
US7396542B2 (en) * 2001-12-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CN1997374A (zh) * 2004-06-23 2007-07-11 默克公司 雌激素受体调节剂
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
WO2007058998A2 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (de) * 1974-03-04 1975-09-11
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
FI962445L (fi) 1996-06-12
SA94150373B1 (ar) 2006-05-27
CZ176396A3 (en) 1996-09-11
CN1071116C (zh) 2001-09-19
CA2178637C (en) 1997-12-23
DK0734260T4 (da) 2008-09-29
WO1995016448A1 (en) 1995-06-22
MY112123A (en) 2001-04-30
BG62755B1 (bg) 2000-07-31
PL314980A1 (en) 1996-09-30
BR9408219A (pt) 1997-08-26
CZ287891B6 (cs) 2001-03-14
NO307366B1 (no) 2000-03-27
DZ1835A1 (fr) 2002-02-17
DE69419033D1 (de) 1999-07-15
JPH09506602A (ja) 1997-06-30
KR100367796B1 (ko) 2003-07-22
MA23395A1 (fr) 1995-07-01
EP0734260B1 (de) 1999-06-09
NO962547L (no) 1996-06-14
CA2274389A1 (en) 1995-06-22
AU697982B2 (en) 1998-10-22
ES2132610T3 (es) 1999-08-16
CA2214575A1 (en) 1995-06-22
EP0734260B2 (de) 2008-07-09
GB9325644D0 (en) 1994-02-16
NO962547D0 (no) 1996-06-14
CA2214575C (en) 1999-12-07
CN1137236A (zh) 1996-12-04
CA2274389C (en) 2004-09-14
UA42745C2 (uk) 2001-11-15
CA2178637A1 (en) 1995-06-22
NZ277790A (en) 1998-02-26
CA2274387A1 (en) 1995-06-22
BG100648A (bg) 1997-02-28
EP0734260A1 (de) 1996-10-02
FI962445A7 (fi) 1996-06-12
SI0734260T2 (sl) 2008-12-31
ZA949900B (en) 1995-10-10
RO115413B1 (ro) 2000-02-28
FI962445A0 (fi) 1996-06-12
HU9601665D0 (en) 1996-08-28
IL111978A0 (en) 1995-03-15
DK0734260T3 (da) 1999-11-15
HK1012285A1 (en) 1999-07-30
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
SI0734260T1 (sl) 1999-08-31
AP540A (en) 1996-09-20
RU2146141C1 (ru) 2000-03-10
JP3037757B2 (ja) 2000-05-08
AP9400704A0 (en) 1995-01-31
SA94150373A (ar) 2005-12-03
IL111978A (en) 2000-07-16
DE69419033T2 (de) 1999-11-25
HUT75880A (en) 1997-05-28
US6113944A (en) 2000-09-05
ES2132610T5 (es) 2008-12-16
SK282620B6 (sk) 2002-10-08
GR3031047T3 (en) 1999-12-31
AU1314595A (en) 1995-07-03

Similar Documents

Publication Publication Date Title
DE69419033D1 (de) Paroxetin enthaltende tabletten und verfahren
DE69419423D1 (de) Verfahren zur verkapselung und daraus hergestellte mikrokapseln
DE69427695D1 (de) Neues verfahren und geraet
EP0809829A4 (de) Gerät und verfahren
DE69435286D1 (de) Verfahren und zusammensetzungen zum hervorrufen von schlaf
DE69421505D1 (de) Mischvorrichtung und Verfahren
DE69616813D1 (de) Halographisches aufzeichnungsmaterial und verfahren
NO20035726D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
DE69413031D1 (de) Robuster sprachprozessor und verfahren
DE69626055D1 (de) Gerät und Verfahren zum Datenschutz
DE69834401D1 (de) Businterfacesystem und verfahren
DE69212502D1 (de) Klebstoffzusammensetzung und verfahren
BR9407089A (pt) Moega e método
DE69433887D1 (de) Verpackungssystem und verpackungsverfahren
DE69411159D1 (de) Strömungsleitende drehkupplung und verfahren
DE69306354D1 (de) Absetzwerkzeug und zugehöriges Verfahren
DE4394395T1 (de) Meßwertwandleranordnung und Verfahren
DE69430006D1 (de) Verbindungen und verfahren
FI962103A0 (fi) Höyrystyslaite ja menetelmä
FI955612A7 (fi) Menetelmä ja laite koneellista astioidenpuhdistusta varten
FI97695C (fi) Suodatusmenetelmä ja -laite
DE69319811D1 (de) Editiermethode und Editiergeräte
DE69415632D1 (de) Filamentwickelverfahren und -vorrichtung
DE69407483D1 (de) Aufzeichnungsgerät und Aufzeichnungsverfahren
FI953921L (fi) Pesumenetelmä ja -koostumus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0734260

Country of ref document: EP

REN Ceased due to non-payment of the annual fee